http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106867964-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-115 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 |
| filingDate | 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106867964-B |
| titleOfInvention | Myocardial cell culture solution and culture method |
| abstract | The invention discloses a culture solution for culturing myocardial cells based on peripheral blood mononuclear cells, which comprises: the culture medium comprises a DMEM/F12 basal medium and Insulin Transferrin Selenite (ITS) supplement liquid in a volume ratio of 100: 0.5-2, an adenylate cyclase activator, L-ascorbic acid, an L-glutamine derivative, a calcium channel activator, an RSK 2 inhibitor, a GSK3 inhibitor and an ALK-4,5 and 7 inhibitor. The invention also discloses a culture method for culturing the myocardial cells based on the peripheral blood mononuclear cells, the culture solution can be used for directionally differentiating and culturing the peripheral blood mononuclear cells as raw materials to obtain the myocardial cells, the materials are convenient to obtain, and moral disputes can be avoided. |
| priorityDate | 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 237.